Multi-award-winning IR veteran talks about how the firm uses its IR Impact successes, how AI is changing the role and the executive exposure she’s enjoyed
In her almost three years as chief investor relations officer at Pfizer, Francesca DeMartino has already racked up two IR Impact trophies and a nomination. In an exclusive interview with IR Impact, she talks about the way the team is set up, the support that IR gets from Pfizer management and other functions across the firm – all of which comes together to allow DeMartino to implement ambitious projects beyond the bread and butter of IR.
Still, it is the Street-facing side of the role – the lunches that let you get inside the minds of investors and analysts, the meetings that allow IR to deliver feedback to the C-suite to really showcase its value – that she would do more of if she could.
Here, DeMartino talks in depth about the Pfizer IR program, how she runs the team and what she loves about the profession.
Enjoy access to this and more – for free!
Log in or create your free My IR – Essentials account to:
- Get access to 3 free IR deep dives
- More than 100 pieces of insight, plus our exclusive CFO interviews
- Save favorites and get personalized content on your dashboard
- Enjoy 10% off all IR forums
